FDA DEVICE FACTS
Ablamap® System
Ablacon, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The Ablamap® System is used to analyze electrogram (EGM) signals and display results in a visual format for evaluation by a physician in order to assist in the diagnosis of complex cardiac arrhythmias. Comparative Technological Characteristics The Ablacon Ablamap ® System is an electrophysiological mapping system that uses a proprietary algorithm to process EGM signals and display electrical wave propagation information in a visual K230008 Ablacon Ablamap® System 3
format during pre -defined time intervals . The intended use, indications for use, and f undamental performance are the same as the primary predicate device. A comparison summary of the technological characteristics of the subject device and the predicate devices are as follows: Device Characteristic Subject Device Ablamap® System (K230008)
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。